Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInovio Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.01 | -$1.01 | -$1.01 |
| Q2 2024 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q3 2024 | 1 | -$1.15 | -$1.15 | -$1.15 |
| Q4 2024 | 4 | -$0.97 | -$0.80 | -$0.92 |
| Q1 2025 | 1 | -$1.08 | -$1.08 | -$1.08 |
| Q2 2025 | 1 | -$0.90 | -$0.90 | -$0.90 |
| Q3 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q4 2025 | 1 | -$0.68 | -$0.68 | -$0.68 |
Inovio Pharmaceuticals, Inc. Earnings Date And Information
Inovio Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.89 earnings per share for the quarter, topping analysts' consensus estimates of $-1.2 by $0.31. The company had revenue of 0 for the quarter and had revenue of 832,010 for the year. Inovio Pharmaceuticals, Inc. has generated $-6 earnings per share over the last year ($-6.09 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Inovio Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Inovio Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$1.20 | -$894.28 | -893.08 | $112,833 | $0 |
| 08/08/2024 | Q2 2024 | -$1.15 | -$1.19 | -0.04 | $134,000 | $100,762 |
| 05/13/2024 | Q1 2024 | -$1.08 | -$1.31 | -0.23 | $0 | |
| 03/06/2024 | Q4 2023 | -$1.27 | -$1.10 | 0.17 | $102,651 | |
| 11/09/2023 | Q3 2023 | -$1.56 | -$1.52 | 0.04 | $116,667 | $388,446 |
| 08/09/2023 | Q2 2023 | -$1.68 | -$1.61 | 0.07 | $275,000 | $225,971 |
| 05/10/2023 | Q1 2023 | -$1.68 | $136.92 | 138.6 | $114,943 | |
| 03/01/2023 | Q4 2022 | -$1.92 | -$2.42 | -0.5 | $124,666 | |
| 11/08/2022 | Q3 2022 | -$3.48 | -$0.16 | 3.32 | $623,167 | $9.15 M |
| 08/09/2022 | Q2 2022 | -$3.60 | -$0.48 | 3.12 | $529,000 | $784,395 |
| 05/10/2022 | Q1 2022 | -$3.36 | -$0.38 | 2.98 | $199,074 | |
| 03/01/2022 | Q4 2021 | -$3.96 | -$0.51 | 3.45 | $839,115 | |
| 11/09/2021 | Q3 2021 | -$3.96 | -$0.29 | 3.67 | $873,600 | $291,698 |
| 08/09/2021 | Q2 2021 | -$3.00 | -$0.39 | 2.61 | $1.09 M | $272,824 |
| 05/10/2021 | Q1 2021 | -$2.16 | -$0.27 | 1.89 | $371,120 | |
| 03/01/2021 | Q4 2020 | -$2.64 | -$0.15 | 2.49 | $5.58 M | |
| 11/09/2020 | Q3 2020 | -$2.16 | $0.12 | 2.28 | $3.05 M | $236,178 |
| 08/10/2020 | Q2 2020 | -$2.16 | -$0.83 | 1.33 | $2.61 M | $267,187 |
| 05/11/2020 | Q1 2020 | -$2.88 | -$0.26 | 2.62 | $1.33 M | |
| 03/12/2020 | Q4 2019 | -$2.76 | -$0.30 | 2.46 | $279,488 |
Inovio Pharmaceuticals, Inc. Earnings: FAQ's
When is Inovio Pharmaceuticals, Inc.'s earnings date?
Inovio Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
Did Inovio Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Inovio Pharmaceuticals, Inc. (:INO) reported $-0.89 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.2 by $0.31.
How can I listen to Inovio Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Inovio Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Inovio Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Inovio Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does Inovio Pharmaceuticals, Inc. generate each year?
Inovio Pharmaceuticals, Inc. (:INO) has a recorded annual revenue of $832,010.
How much profit does Inovio Pharmaceuticals, Inc. generate each year?
Inovio Pharmaceuticals, Inc. (:INO) has a recorded net income of $832,010. Inovio Pharmaceuticals, Inc. has generated $-6.09 earnings per share over the last four quarters.
What is Inovio Pharmaceuticals, Inc.'s price-to-earnings ratio?
Inovio Pharmaceuticals, Inc. (:INO) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.